A narrative review (PMC8020175) evaluated beetroot as a functional food for cancer chemoprevention and found that betacyanins, the dominant betalains in red beets, demonstrate anti-proliferative effects in multiple cancer cell lines, including colon, breast, liver, and lung cancers. Proposed mechanisms include: inhibition of tumor cell proliferation through G2/M cell cycle arrest, induction of apoptosis via caspase pathway activation, suppression of angiogenesis (blocking VEGF expression), and reduction of metastasis-related gene expression. Betanin (the primary betacyanin pigment) also acts as a potent free radical scavenger and inhibits lipid peroxidation, reducing the oxidative DNA damage that initiates carcinogenesis. A 2021 functional food review (PMC8565237) confirmed significant antitumor activity in animal models, though noting that human clinical evidence for cancer prevention specifically remains limited, most data come from cell and animal studies. The evidence positions beets as a promising cancer-preventive food, but “emerging” credibility reflects the need for human trials.
Beets are one of the richest dietary sources of inorganic nitrates (250–500 mg per 100g). The nitrate-nitrite-nitric oxide pathway converts dietary nitrate to nitric oxide in the body, which relaxes vascular smooth muscle, dilates blood vessels, and reduces peripheral resistance. Meta-analyses of beetroot juice supplementation consistently show significant reductions in systolic blood pressure, typically 3–5 mmHg, achieved within hours and sustained with regular consumption. This effect is comparable to some antihypertensive medications in magnitude for individuals with mildly elevated blood pressure. Beets also contain betaine, which reduces homocysteine levels, an independent cardiovascular risk factor.
Nitrate-driven nitric oxide production improves oxygen delivery efficiency to working muscles and reduces the ATP cost of muscle contraction. Multiple RCTs have demonstrated that beetroot juice consumed 2–3 hours before exercise reduces the oxygen cost of submaximal exercise by 3–5% and extends time-to-exhaustion. These effects are most pronounced in recreational athletes and endurance sports. This is one of the most evidence-backed dietary ergogenic aids available without banned-substance concerns.
Betacyanins inhibit pro-inflammatory NF-κB signaling and reduce production of TNF-α, IL-6, and CRP in animal models. Betaine acts as an osmoprotectant and methyl donor with independent anti-inflammatory properties. While the human anti-inflammatory data is less developed than the cardiovascular evidence, the mechanistic case is well supported.